Compile Data Set for Download or QSAR
maximum 50k data
Found 38 Enz. Inhib. hit(s) with all data for entry = 8419
TargetVoltage-dependent N-type calcium channel subunit alpha-1B(Homo sapiens (Human))
Newron Pharmaceuticals

US Patent
LigandPNGBDBM247250(US9447029, 1-1)
Affinity DataKi:  100nMAssay Description:Cells and methods: Functional inhibition of the sodium currents is studied using whole cell patch clamp methods (Hamill O. P., Marty A., Neher E., Sa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVoltage-dependent N-type calcium channel subunit alpha-1B(Homo sapiens (Human))
Newron Pharmaceuticals

US Patent
LigandPNGBDBM247253(US9447029, 1-6)
Affinity DataKi:  100nMAssay Description:Cells and methods: Functional inhibition of the sodium currents is studied using whole cell patch clamp methods (Hamill O. P., Marty A., Neher E., Sa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVoltage-dependent N-type calcium channel subunit alpha-1B(Homo sapiens (Human))
Newron Pharmaceuticals

US Patent
LigandPNGBDBM247254(US9447029, 1-7)
Affinity DataKi:  100nMAssay Description:Cells and methods: Functional inhibition of the sodium currents is studied using whole cell patch clamp methods (Hamill O. P., Marty A., Neher E., Sa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVoltage-dependent N-type calcium channel subunit alpha-1B(Homo sapiens (Human))
Newron Pharmaceuticals

US Patent
LigandPNGBDBM247256(US9447029, 1-15)
Affinity DataKi:  200nMAssay Description:Cells and methods: Functional inhibition of the sodium currents is studied using whole cell patch clamp methods (Hamill O. P., Marty A., Neher E., Sa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVoltage-dependent N-type calcium channel subunit alpha-1B(Homo sapiens (Human))
Newron Pharmaceuticals

US Patent
LigandPNGBDBM247257(US9447029, 1-18)
Affinity DataKi:  200nMAssay Description:Cells and methods: Functional inhibition of the sodium currents is studied using whole cell patch clamp methods (Hamill O. P., Marty A., Neher E., Sa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVoltage-dependent N-type calcium channel subunit alpha-1B(Homo sapiens (Human))
Newron Pharmaceuticals

US Patent
LigandPNGBDBM247260(US9447029, 1-32)
Affinity DataKi:  300nMAssay Description:Cells and methods: Functional inhibition of the sodium currents is studied using whole cell patch clamp methods (Hamill O. P., Marty A., Neher E., Sa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVoltage-dependent N-type calcium channel subunit alpha-1B(Homo sapiens (Human))
Newron Pharmaceuticals

US Patent
LigandPNGBDBM247255(US9447029, 1-14)
Affinity DataKi:  500nMAssay Description:Cells and methods: Functional inhibition of the sodium currents is studied using whole cell patch clamp methods (Hamill O. P., Marty A., Neher E., Sa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVoltage-dependent N-type calcium channel subunit alpha-1B(Homo sapiens (Human))
Newron Pharmaceuticals

US Patent
LigandPNGBDBM247259(US9447029, 1-29)
Affinity DataKi:  700nMAssay Description:Cells and methods: Functional inhibition of the sodium currents is studied using whole cell patch clamp methods (Hamill O. P., Marty A., Neher E., Sa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVoltage-dependent N-type calcium channel subunit alpha-1B(Homo sapiens (Human))
Newron Pharmaceuticals

US Patent
LigandPNGBDBM247264(US9447029, 4-1)
Affinity DataKi:  1.10E+3nMAssay Description:Cells and methods: Functional inhibition of the sodium currents is studied using whole cell patch clamp methods (Hamill O. P., Marty A., Neher E., Sa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVoltage-dependent N-type calcium channel subunit alpha-1B(Homo sapiens (Human))
Newron Pharmaceuticals

US Patent
LigandPNGBDBM247263(US9447029, 3-3)
Affinity DataKi:  1.70E+3nMAssay Description:Cells and methods: Functional inhibition of the sodium currents is studied using whole cell patch clamp methods (Hamill O. P., Marty A., Neher E., Sa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 2D6(Homo sapiens (Human))
Newron Pharmaceuticals

US Patent
LigandPNGBDBM247267(US9447029, 2-[2-(3-Butoxyphenyl)-ethylamino]-N,N-d...)
Affinity DataIC50:  700nMT: 2°CAssay Description:Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 2D6(Homo sapiens (Human))
Newron Pharmaceuticals

US Patent
LigandPNGBDBM247271(US9447029, 2-[2-(3-Hexyloxyphenyl)-ethylamino]-N,N...)
Affinity DataIC50:  900nMT: 2°CAssay Description:Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 2D6(Homo sapiens (Human))
Newron Pharmaceuticals

US Patent
LigandPNGBDBM247268(US9447029, 2-[2-(3-Butoxyphenyl)-ethylamino]-1-(pi...)
Affinity DataIC50:  1.10E+3nMT: 2°CAssay Description:Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 2D6(Homo sapiens (Human))
Newron Pharmaceuticals

US Patent
LigandPNGBDBM247273(US9447029, 2-{2-[3-(4,4,4-trifluorobutoxy)phenyl]-...)
Affinity DataIC50:  1.80E+3nMT: 2°CAssay Description:Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 2D6(Homo sapiens (Human))
Newron Pharmaceuticals

US Patent
LigandPNGBDBM247266(US9447029, 2-[2-(3-Butoxyphenyl)-ethylamino]-N,N-d...)
Affinity DataIC50:  2.50E+3nMT: 2°CAssay Description:Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 2D6(Homo sapiens (Human))
Newron Pharmaceuticals

US Patent
LigandPNGBDBM247265(US9447029, 2-[2-(3-Butoxyphenyl)-ethylamino]-1-(py...)
Affinity DataIC50:  3.00E+3nMT: 2°CAssay Description:Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 2D6(Homo sapiens (Human))
Newron Pharmaceuticals

US Patent
LigandPNGBDBM247275(US9447029, 2-{[2-(3-Butoxyphenyl)-ethyl]-(2-methox...)
Affinity DataIC50:  3.40E+3nMT: 2°CAssay Description:Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 2D6(Homo sapiens (Human))
Newron Pharmaceuticals

US Patent
LigandPNGBDBM247270(US9447029, 2-[2-(3-Pentyloxyphenyl)-ethylamino]-N,...)
Affinity DataIC50:  3.50E+3nMT: 2°CAssay Description:Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 2D6(Homo sapiens (Human))
Newron Pharmaceuticals

US Patent
LigandPNGBDBM247272(US9447029, 2-{2-[3-(4,4,4-trifluorobutoxy)-phenyl]...)
Affinity DataIC50:  5.00E+3nMT: 2°CAssay Description:Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 2D6(Homo sapiens (Human))
Newron Pharmaceuticals

US Patent
LigandPNGBDBM161090(US9051240, 2-[2-(3-Butoxyphenyl)-ethylamino]-N,N-d...)
Affinity DataIC50:  5.80E+3nMT: 2°CAssay Description:Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCytochrome P450 2D6(Homo sapiens (Human))
Newron Pharmaceuticals

US Patent
LigandPNGBDBM161093(US9051240, 2-[2-(3-Butoxyphenyl)-ethylamino]-N,N-d...)
Affinity DataIC50:  5.80E+3nMT: 2°CAssay Description:Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCytochrome P450 2D6(Homo sapiens (Human))
Newron Pharmaceuticals

US Patent
LigandPNGBDBM161090(US9051240, 2-[2-(3-Butoxyphenyl)-ethylamino]-N,N-d...)
Affinity DataIC50:  5.80E+3nMT: 2°CAssay Description:Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCytochrome P450 2D6(Homo sapiens (Human))
Newron Pharmaceuticals

US Patent
LigandPNGBDBM247269(US9447029, 2-{[2-(3-Butoxyphenyl)-ethyl]-(3-methox...)
Affinity DataIC50:  7.30E+3nMT: 2°CAssay Description:Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 2D6(Homo sapiens (Human))
Newron Pharmaceuticals

US Patent
LigandPNGBDBM247274(US9447029, 2-[2-(3-Benzyloxyphenyl)-ethylamino]-N,...)
Affinity DataIC50:  1.06E+4nMT: 2°CAssay Description:Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 2D6(Homo sapiens (Human))
Newron Pharmaceuticals

US Patent
LigandPNGBDBM247252(US9447029, 1-3)
Affinity DataIC50:  2.39E+4nMT: 2°CAssay Description:Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 2D6(Homo sapiens (Human))
Newron Pharmaceuticals

US Patent
LigandPNGBDBM247260(US9447029, 1-32)
Affinity DataIC50:  3.40E+4nMT: 2°CAssay Description:Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 2D6(Homo sapiens (Human))
Newron Pharmaceuticals

US Patent
LigandPNGBDBM247253(US9447029, 1-6)
Affinity DataIC50:  3.78E+4nMT: 2°CAssay Description:Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 2D6(Homo sapiens (Human))
Newron Pharmaceuticals

US Patent
LigandPNGBDBM247259(US9447029, 1-29)
Affinity DataIC50:  3.83E+4nMT: 2°CAssay Description:Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 2D6(Homo sapiens (Human))
Newron Pharmaceuticals

US Patent
LigandPNGBDBM247261(US9447029, 2-1)
Affinity DataIC50: >4.00E+4nMT: 2°CAssay Description:Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 2D6(Homo sapiens (Human))
Newron Pharmaceuticals

US Patent
LigandPNGBDBM247263(US9447029, 3-3)
Affinity DataIC50: >4.00E+4nMT: 2°CAssay Description:Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 2D6(Homo sapiens (Human))
Newron Pharmaceuticals

US Patent
LigandPNGBDBM247264(US9447029, 4-1)
Affinity DataIC50: >4.00E+4nMT: 2°CAssay Description:Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 2D6(Homo sapiens (Human))
Newron Pharmaceuticals

US Patent
LigandPNGBDBM247256(US9447029, 1-15)
Affinity DataIC50: >4.00E+4nMT: 2°CAssay Description:Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 2D6(Homo sapiens (Human))
Newron Pharmaceuticals

US Patent
LigandPNGBDBM247250(US9447029, 1-1)
Affinity DataIC50: >4.00E+4nMT: 2°CAssay Description:Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 2D6(Homo sapiens (Human))
Newron Pharmaceuticals

US Patent
LigandPNGBDBM247251(US9447029, 1-2)
Affinity DataIC50: >4.00E+4nMT: 2°CAssay Description:Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 2D6(Homo sapiens (Human))
Newron Pharmaceuticals

US Patent
LigandPNGBDBM247257(US9447029, 1-18)
Affinity DataIC50: >4.00E+4nMT: 2°CAssay Description:Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 2D6(Homo sapiens (Human))
Newron Pharmaceuticals

US Patent
LigandPNGBDBM247258(US9447029, 1-21)
Affinity DataIC50: >4.00E+4nMT: 2°CAssay Description:Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 2D6(Homo sapiens (Human))
Newron Pharmaceuticals

US Patent
LigandPNGBDBM247255(US9447029, 1-14)
Affinity DataIC50: >4.00E+4nMT: 2°CAssay Description:Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 2D6(Homo sapiens (Human))
Newron Pharmaceuticals

US Patent
LigandPNGBDBM247262(US9447029, 3-2)
Affinity DataIC50: >4.00E+4nMT: 2°CAssay Description:Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent